Newsroom

Featured

Xylo Bio Achieves Clinical-Stage Milestone with XYL-1001, a Highly Selective Neuroplastogen Targeting Major Depressive Disorder

September 15, 2026

PR Newswire

Xylo Bio Joins Third Cohort of One Mind Accelerator Mental Health Startups

February 24, 2025

Business Wire

Psylo Rebrands as Xylo Bio, with Key Board Appointments and Breakthrough Pipeline Progress

January 10, 2025

PR Newswire

$3M grant to accelerate development of neuroplastogens for substance use disorder treatment

October 28, 2024

PR Newswire

Psylo ft. in Nature Article: Next-generation psychedelics: should new agents skip the trip?

April 3, 2024

Nature Biotechnology

Psylo Announces First Close on $8 Million Series Seed Financing to Advance Next-Generation Neuroplastogens at BIO Conference in San Diego

April 3, 2024

PR Newswire

Psylo announces sponsored research agreement with Daiichi Sankyo to develop non-hallucinogenic psychiatric therapies

June 22, 2023

PR Newswire

All Coverage

Xylo Bio Clinical Stage News ft. in Psychedelic Alpha Bulletin #231

September 16, 2026

Psychedelic Alpha

Xylo Bio Attends Serotonergic and Neurotherapeutic Conference Double Header

April 12, 2026

Lucid News

Co-founder Josh Ismin Featured on When (A)I Grow Up Podcast

November 17, 2025

When (A)I Grow Up

Co-founders Josh Ismin and Dr. Sam Banister on XEIA Human 3 Podcast

July 8, 2025

Human 3 Podcast

Co-founder Josh Ismin featured on Startup 360 Podcast

May 16, 2025

Startup Daily

Psylo part of $6 million boost for industry research projects at University of Sydney

October 25, 2024

The University of Sydney

How Psylo and Enosis Therapeutics are using tech to tackle medicinal psychdelics

September 18, 2024

Smart Company

Psylo Partnership to Deliver Psychedelic Treatments for Mental Health

June 27, 2024

University of Sydney

Psylo's US trip: why the psychedelics startup is keeping one foot in Australia as it expands stateside

June 24, 2024

Capital Brief

Psylo mentioned in Scientific American Article: Should Next-Generation Psychdelics Skip the Trip?

April 22, 2024

Scientific American

Five Aussie startups that raised $54.4 million this week

April 7, 2024

Smart Company

Biotech startup Psylo closes $8M seed round on psychedelic treatment

April 4, 2024

Capital Brief

Superseeder: psychedelic biotech Psylo plants $12M in latest ‘Seed’ round

April 4, 2024

Startup Daily

CSO Dr. Sam Banister featured on Psychedelics Today

March 1, 2024

Psychedelics Today

Dr. Dilara Bahceci guest writes for Psychedelic Alpha on equitable drug development

January 25, 2024

Psychedelic Alpha

Co-founder Josh Ismin's talk for TEDxSydney 2023

November 3, 2023

TEDxSydney

Dr Will Jorgensen was a guest on the 018 Hello Tomorrow AP 2023 Recap Show

September 27, 2023

One North Stories

Dr. Dilara Bahceci featured on The Scan Podcast

August 30, 2023

The Scan

Dr. Dilara Bahceci: Future Medicine Podcast

August 8, 2023

Humans of Purpose

CSO Dr. Sam Banister gives seminar to Entheogenesis Australis

July 1, 2023

Entheogenesis Australis

Xylo Featured in Pα+ Psychedelic Bulletin #140

June 29, 2023

Psychedelic Alpha

Dr. Alex Kwan featured: Timing is key for behavioral benefits of psychedelics

June 14, 2023

Nature

Dr. Mario de la Fuente featured on Psychedelic Brain Science Podcast

June 13, 2023

Psychedelic Brain Science

Co-founder Josh Ismin Speaks at 2023 Mind the Gap Seminar

May 15, 2023

Mind the Gap

CSO Dr. Sam Banister featured Speaker for Webinar on Psychedelics Research

March 28, 2023

CDD Vault

Biotechs scramble as Australia leads world in psychedelics

February 6, 2023

Australia's FInancial Review

Psylo reaction to TGA down-scheduling psilocybin and MDMA

February 2, 2023

Medium

UNSW and Xylo CSO Dr. Sam Banister Featured on Channel 9 News Australia

January 9, 2023

Channel 9 News Australia

UNSW Founders 2022 10x Accelerator Demo Day showcases next herd of unicorns to investors

November 22, 2022

UNSW Founders

Purpose 2022 Interview with Dr. Banister and Joshua Ismin

November 2, 2022

Matters

The big name VCs backing Aussie magic mushrooms start-up

October 27, 2022

Australia's FInancial Review

Dr. Will Jorgensen featured on The Lead Candidate

October 17, 2022

The Lead Candidate

UNSW Science Partner Stories

September 1, 2022

UNSW Community

Psychedelic Alpha Interview with Josh Ismin

August 19, 2022

Psychdelic Alpha